In patients with asthma, elevations of non-type-2 signals such as IL-6 correspond with higher blood neutrophil counts, obesity, a lower percent predicted FEV1, increased asthma-related hospitalizations, and increased use of systemic corticosteroids. The gene discussed is IL6; the disease is asthma.